Table 2 Patients’ characteristics.
Variable | No. of studies | UAE group, % (n/N) | MYO group, % (n/N) |
|---|---|---|---|
No. of patients | 9 | 11,887 | 24,469 |
Age, years | 8 | 43.3 | 39.5 |
Race | |||
White | 4 | 40.9% (2698/6587) | 32.9% (3320/10,087) |
Black | 4 | 24.3% (1601/6587) | 35.4% (3573/10,087) |
Other | 4 | 34.8% (2288/6587) | 31.3% (3194/10,087) |
Subfertility | 3 | 13.1% (650/4954) | 15.1% (2158/14,373) |
Pelvic pain | 3 | 24.5% (399/1623) | 12.1% (16,700/5619) |
Bleeding symptoms | 3 | 38.7% (1918/4954) | 38.8% (5579/14,373) |
Largest fibroid’s location | |||
Submucosa | 2 | 9.4% (26/276) | 11.2% (21/187) |
Subserosa | 2 | 29.3% (81/276) | 27.3% (51/187) |
Muscle wall | 2 | 21.7% (60/276) | 32.1% (60/187) |
No. of fibroids | |||
1–3 no. (%) | 2 | 56.2% (155/276) | 58.3% (109/187) |
4–10 no. (%) | 2 | 25.3% (70/276) | 31.5% (59/187) |
> 10 no. (%) | 2 | 29.3% (81/276) | 12.1% (19/187) |
Gravidity | 3 | 86.9% (298/343) | 78.8% (526/676) |
Uterine volume, cm3 | 4 | 796.6 | 731.7 |
